Imatinib Completed Phase 4 Trials for Chronic Myelogenous Leukemia (CML) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00171899Study Comparing Standard Dose and High-dose Imatinib Mesylate in Patients With Chronic Phase Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML)
NCT00081926Gleevec Trial in Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia